Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

About

Umit Tapan, MD, is a thoracic oncologist at Boston Medical Center (BMC) and an assistant professor of Medicine at Boston University Chobanian & Avedisian School of Medicine. Dr. Tapan specializes in non-small cell lung cancer, small cell lung cancer, mesothelioma, immunotherapy, targeted therapy/precision medicine. His research interests center on reducing disparities in lung cancer treatment, improving access to new treatments such as immunotherapy and targeted treatment. After receiving his medical degree from Hacettepe University School of Medicine in Turkey, Dr. Tapan completed his internship and residency at Steward Carney Hospital and a fellowship in hematology and oncology at Boston University Medical Center.
  • Specialties

    Non-small cell lung cancer, small-cell lung cancer, mesothelioma, immunotherapy, targeted therapy

  • Languages

    Turkish
  • Administrative Title

    Assistant Professor of Medicine, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine. Member, BU-BMC Cancer Center. Member, Evans Center for Interdisciplinary Biomedical Research, Boston University.

  • Residency

    Internal Medicine, Steward Carney Hospital, 2010-2012
  • Fellowship

    Hematology and Medical Oncology, Boston University Medical Center, 2014-2015
  • Education

    Hacettepe University Faculty of Medicine, Turkey, 2006
  • Board Certifications

    Internal Medicine, Hematology, Medical Oncology, American Board of Internal Medicine
  • Research Interests

    Disparities in lung cancer care, predictors of immunotherapy response/toxicity

Affiliations

Affiliations